SCHEMBL11906754

SCHEMBL11906754

C=C[C]=CC=CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21433566 1.00
SCHEMBL31274452 0.72
SCHEMBL5153034 0.72
SCHEMBL459324 0.69
SCHEMBL459323 0.69
SCHEMBL22112 0.67
SCHEMBL22111 0.67
SCHEMBL1760692 0.67
SCHEMBL781842 0.67
SCHEMBL2346382 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116354926-A Heterocyclic compounds as Pol theta inhibitors, process for their preparation and their use 武汉人福创新药物研发中心有限公司 2023-06-30 CN disclosed
CN-111542525-B Selective inhibitors of protein arginine methyltransferase 5 (PRMT 5) 普莱鲁德疗法有限公司 2023-06-27 CN disclosed
CN-114249652-A Phenol derivative and application thereof in medicine 天地恒一制药股份有限公司 2022-03-29 CN disclosed
CN-107068914-B Hole transport compositions and related devices and methods (I) 日产化学工业株式会社 2020-05-08 CN disclosed
EP-3548578-A1 POLYMER FOR THERMAL INTERFACE WITH LOW THERMAL RESISTANCE AND THERMAL INTERFACE Thales (FR) 2019-10-09 EP disclosed
EP-2492262-B1 FUSED HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR NISSAN CHEMICAL IND LTD (JP) 2016-04-20 EP disclosed
US-8889732-B2 Fused heterocyclic compounds and thrombopoietin receptor activators NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-11-18 US disclosed
EP-2492262-A1 FUSED HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR Nissan Chemical Industries, Ltd. (JP) 2012-08-29 EP disclosed
US-20120209005-A1 FUSED HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-08-16 US disclosed